MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rouot, B.
Right arrow Articles by Homburger, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rouot, B.
Right arrow Articles by Homburger, V.

Specific antibodies against Go isoforms reveal the early expression of the Go2 alpha subunit and appearance of Go1 alpha during neuronal differentiation

B Rouot, N Charpentier, C Chabbert, J Carrette, R Zumbihl, J Bockaert and V Homburger

Centre CNRS-INSERM de Pharmacologie et Endocrinologie, Montpellier, France.

We have previously identified two isoforms of Go alpha in membranes of N1E-115 neuroblastoma cells, using an antibody raised against the purified Go alpha subunit; one isoform of the Go alpha subunit (pI 5.80) is present in undifferentiated cells, whereas a more acidic isoform (pI 5.55) appears during differentiation [J. Neurochem. 54:1310- 1320 (1990)]. Recently, the Go alpha gene has been shown to encode, by alternative splicing, two polypeptides, Go1 alpha and Go2 alpha, which differ only in their carboxyl-terminal part. To determine unambiguously whether the two Go alpha subunits detected in neuroblastoma cells were actually the products of different mRNAs, rabbit polyclonal antibodies were generated against synthetic peptides (amino acids 291-302) of both sequences. Specificity of the two affinity-purified antipeptide antibodies was assessed on Western blots by comparing their immunoreactivities with those of other G alpha antibodies. On a blotted mixture of purified brain guanine nucleotide-binding proteins, the anti- alpha o1 and anti-alpha o2 peptide antibodies only recognized the 39- kDa Go alpha subunit. Furthermore, the immunological recognition of brain membranes from 15-day-old mouse fetuses by antipeptide antibodies could be specifically blocked by addition of the corresponding antigen. When membrane proteins from differentiated neuroblastoma cells and mouse fetus brain were blotted after two-dimensional gel electrophoresis, the anti-alpha o1 and anti-alpha o2 peptide antibodies labeled a 39-kDa subunit focused at a pI value of 5.55 or 5.80, respectively. Study of the ontogenesis of both Go alpha subunits revealed the predominance of Go2 alpha in the frontal cortex at day 15 of gestation. Thereafter, there was a progressive decline of the Go2 alpha polypeptide to a very low level, concomitant with an increase in the Go1 alpha protein, which plateaued about 15 days after birth to a level 8 times higher than at gestational day 15. Similarly, on neuroblastoma cells, the Go2 alpha subunit was almost exclusively present in undifferentiated cells, and differentiation induced the appearance of the Go1 alpha subunit, with a reduction in the amount of Go2 alpha polypeptide. Thus, the evolution of the two Go alpha subunits during cell differentiation, unambiguously identified with specific antibodies, suggests that neuronal differentiation is responsible for the on/off switch of the expression of the Go alpha isoforms and indicates that Go1 alpha, rather than Go2 alpha, is involved in neurotransmission.

Volume 41, Issue 2, pp. 273-280, 02/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Neurosci.Home page
A. Dhingra, M. Jiang, T.-L. Wang, A. Lyubarsky, A. Savchenko, T. Bar-Yehuda, P. Sterling, L. Birnbaumer, and N. Vardi
Light Response of Retinal ON Bipolar Cells Requires a Specific Splice Variant of Galpha o
J. Neurosci., June 15, 2002; 22(12): 4878 - 4884.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Rasolonjanahary, C. Gerard, M. N. Dufour, V. Homburger, A. Enjalbert, and G. Guillon
Evidence for a Direct Negative Coupling between Dopamine-D2 Receptors and PLC by Heterotrimeric Gi1/2 Proteins in Rat Anterior Pituitary Cell Membranes
Endocrinology, March 1, 2002; 143(3): 747 - 754.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Breault, E. Chamoux, J.-G. LeHoux, and N. Gallo-Payet
Localization of G Protein {{alpha}}-Subunits in the Human Fetal Adrenal Gland
Endocrinology, December 1, 2000; 141(12): 4334 - 4341.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
P. Duc-Goiran, C. Bourgeois, T.M. Mignot, B. Robert, G. Tanguy, and F. Ferré
Identification and Expression of Go1 and Go2 {alpha}-Subunit Transcripts in Human Myometrium in Relation to Pregnancy
Biol Reprod, June 1, 1999; 60(6): 1528 - 1535.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. Lagriffoul, N. Charpentier, J. Carrette, C. Tougard, J. Bockaert, and V. Homburger
Secretion of Protease Nexin-1 by C6 Glioma Cells Is under the Control of a Heterotrimeric G Protein, Go1
J. Biol. Chem., December 6, 1996; 271(49): 31508 - 31516.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Bacqueville, P. Deleris, C. Mendre, M.-T. Pieraggi, H. Chap, G. Guillon, B. Perret, and M. Breton-Douillon
Characterization of a G Protein-activated Phosphoinositide 3-Kinase in Vascular Smooth Muscle Cell Nuclei
J. Biol. Chem., June 15, 2001; 276(25): 22170 - 22176.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1992 by the American Society for Pharmacology and Experimental Therapeutics